John R. Lever

3.4k total citations
98 papers, 2.5k citations indexed

About

John R. Lever is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, John R. Lever has authored 98 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Molecular Biology, 62 papers in Cellular and Molecular Neuroscience and 19 papers in Organic Chemistry. Recurrent topics in John R. Lever's work include Receptor Mechanisms and Signaling (51 papers), Pharmacological Receptor Mechanisms and Effects (34 papers) and Neuropeptides and Animal Physiology (30 papers). John R. Lever is often cited by papers focused on Receptor Mechanisms and Signaling (51 papers), Pharmacological Receptor Mechanisms and Effects (34 papers) and Neuropeptides and Animal Physiology (30 papers). John R. Lever collaborates with scholars based in United States, Vietnam and Italy. John R. Lever's co-authors include Susan Z. Lever, Robert F. Dannals, Hayden T. Ravert, Henry N. Wagner, Ursula Scheffel, Roxanne A. Vaughan, John L. Musachio, Alan A. Wilson, J. James Frost and James D. Foster and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

John R. Lever

98 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John R. Lever United States	26	1.2k	1.1k	339	280	214	98	2.5k
John Hilton United States	31	1.2k 1.0×	704 0.6×	942 2.8×	93 0.3×	179 0.8×	64	3.6k
Jacob Madsen Denmark	33	576 0.5×	726 0.7×	705 2.1×	315 1.1×	126 0.6×	102	2.7k
Michael Honer Switzerland	33	1.5k 1.2×	1.0k 0.9×	1.4k 4.2×	546 1.9×	248 1.2×	72	4.2k
Ming‐Qiang Zheng United States	25	714 0.6×	685 0.6×	344 1.0×	67 0.2×	180 0.8×	81	1.7k
Emanuel Escher Canada	39	3.0k 2.4×	1.6k 1.5×	483 1.4×	357 1.3×	141 0.7×	192	4.7k
Françoise Hinnen France	26	1.1k 0.8×	424 0.4×	718 2.1×	353 1.3×	79 0.4×	66	2.2k
Aleksandra Misicka Poland	30	1.8k 1.5×	1.1k 1.0×	57 0.2×	283 1.0×	181 0.8×	160	3.3k
Guido Slegers Belgium	27	921 0.7×	480 0.4×	1.1k 3.1×	113 0.4×	142 0.7×	166	3.2k
Mercedes Delgado Spain	23	886 0.7×	386 0.3×	94 0.3×	581 2.1×	101 0.5×	65	2.1k
C. Prenant France	21	538 0.4×	557 0.5×	726 2.1×	132 0.5×	175 0.8×	67	1.8k

Countries citing papers authored by John R. Lever

Since Specialization

Citations

This map shows the geographic impact of John R. Lever's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John R. Lever with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John R. Lever more than expected).

Fields of papers citing papers by John R. Lever

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John R. Lever. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John R. Lever. The network helps show where John R. Lever may publish in the future.

Co-authorship network of co-authors of John R. Lever

This figure shows the co-authorship network connecting the top 25 collaborators of John R. Lever. A scholar is included among the top collaborators of John R. Lever based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John R. Lever. John R. Lever is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lever, John R., et al.. (2019). Allosteric modulation of sigma receptors by BH3 mimetics ABT-737, ABT-263 (Navitoclax) and ABT-199 (Venetoclax). Pharmacological Research. 142. 87–100. 19 indexed citations

Lever, John R., et al.. (2019). Design, synthesis and evaluation of 111In labeled DOTA-conjugated tetrapeptides having high affinity and selectivity for mu opioid receptors. Nuclear Medicine and Biology. 70. 53–66. 5 indexed citations

Miller, Dennis K., et al.. (2016). N -phenylpropyl- N ′-substituted piperazines occupy sigma receptors and alter methamphetamine-induced hyperactivity in mice. Pharmacology Biochemistry and Behavior. 150-151. 198–206. 4 indexed citations

Lever, Susan Z., et al.. (2016). Tactics for preclinical validation of receptor-binding radiotracers. Nuclear Medicine and Biology. 44. 4–30. 21 indexed citations

Lever, John R., et al.. (2014). Relationship between Cerebral Sigma-1 Receptor Occupancy and Attenuation of Cocaine’s Motor Stimulatory Effects in Mice by PD144418. Journal of Pharmacology and Experimental Therapeutics. 351(1). 153–163. 25 indexed citations

Pramod, Akula Bala, James D. Foster, Joo Hwan, et al.. (2014). Computational and Biochemical Docking of the Irreversible Cocaine Analog RTI 82 Directly Demonstrates Ligand Positioning in the Dopamine Transporter Central Substrate-binding Site. Journal of Biological Chemistry. 289(43). 29712–29727. 21 indexed citations

Fitzsimmons, Jonathan, John R. Lever, & Susan Z. Lever. (2011). Synthesis and σ1 Receptor Binding of Halogenated N,N´-Diphenethylethylenediamines. Medicinal Chemistry. 1(1). 1 indexed citations

Cutler, Cathy, Para Kan, Nripen Chanda, et al.. (2010). Preparation and use of 198Au/199Au for potential applications in cancer therapy and imaging. Transactions of the American Nuclear Society. 103(1). 1123–1124. 2 indexed citations

Lapinsky, David J., Yi Liu, Christopher K. Surratt, et al.. (2010). Azido-iodo-N-benzyl derivatives of threo-methylphenidate (Ritalin, Concerta): Rational design, synthesis, pharmacological evaluation, and dopamine transporter photoaffinity labeling. Bioorganic & Medicinal Chemistry. 19(1). 504–512. 12 indexed citations

10.

Lever, Susan Z., et al.. (2010). SA 4503 attenuates cocaine-induced hyperactivity and enhances methamphetamine substitution for a cocaine discriminative stimulus. Pharmacology Biochemistry and Behavior. 97(4). 676–682. 26 indexed citations

11.

Lapinsky, David J., Shaili Aggarwal, Christopher K. Surratt, et al.. (2009). A novel photoaffinity ligand for the dopamine transporter based on pyrovalerone. Bioorganic & Medicinal Chemistry. 17(11). 3770–3774. 8 indexed citations

12.

Foster, James D., et al.. (2008). Phorbol ester induced trafficking‐independent regulation and enhanced phosphorylation of the dopamine transporter associated with membrane rafts and cholesterol. Journal of Neurochemistry. 105(5). 1683–1699. 108 indexed citations

13.

Lever, John R., et al.. (2006). σ1 and σ2 receptor binding affinity and selectivity of SA4503 and fluoroethyl SA4503. Synapse. 59(6). 350–358. 90 indexed citations

14.

Vaughan, Roxanne A., Jon D. Gaffaney, John R. Lever, Maarten E. A. Reith, & Aloke K. Dutta. (2001). Dual Incorporation of Photoaffinity Ligands on Dopamine Transporters Implicates Proximity of Labeled Domains. Molecular Pharmacology. 59(5). 1157–1164. 25 indexed citations

15.

Dutta, Aloke K., Roxanne A. Vaughan, Jon D. Gaffaney, et al.. (2001). Design, synthesis, and characterization of a novel, 4-[2-(diphenylmethoxy)ethyl]-1-benzyl piperidine-based, dopamine transporter photoaffinity label. Life Sciences. 68(16). 1839–1849. 14 indexed citations

16.

Lever, John R., Ursula Scheffel, Marigo Stathis, et al.. (1996). Synthesis and in vivo studies of a selective ligand for the dopamine transporter: 3β-(4-[125I]iodophenyl) tropan-2β-carboxylic acid isopropyl ester ([125I]RTM-21). Nuclear Medicine and Biology. 23(3). 277–284. 18 indexed citations

17.

Musachio, John L. & John R. Lever. (1992). Vinylstannylated alkylating agents as prosthetic groups for radioiodination of small molecules: design, synthesis, and application to iodoallyl analogs of spiperone and diprenorphine. Bioconjugate Chemistry. 3(2). 167–175. 26 indexed citations

18.

Lever, John R., Ursula Scheffel, Hayden T. Ravert, et al.. (1992). In vivo binding of N1′-([11C]methyl)naltrindole to δ-opioid receptors in mouse brain. European Journal of Pharmacology. 216(3). 459–460. 31 indexed citations

19.

Lever, John R., Samuel M. Mazza, Robert F. Dannals, et al.. (1990). Facile synthesis of [11C]buprenorphine for positron emission tomographic studies of opioid receptors. International Journal of Radiation Applications and Instrumentation Part A Applied Radiation and Isotopes. 41(8). 745–752. 19 indexed citations

20.

Lever, John R., Robert F. Dannals, Alan A. Wilson, et al.. (1989). Synthesis and in vivo characterization of d-(+)-(N1-[11C]methyl)-2-Br-LSD: a radioligand for positron emission tomographic studies of serotonin 5-HT2 receptors. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 16(7). 697–704. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact